Regression of Fibrosis Following Hepatitis C Eradication.
作者信息
Friedman Scott L
机构信息
Fishberg Professor of Medicine Dean for Therapeutic Discovery Chief, Division of Liver Diseases Icahn School of Medicine at Mount Sinai New York, New York.
出版信息
Gastroenterol Hepatol (N Y). 2022 Oct;18(10):599-601.
Abstract
摘要
相似文献
1
Regression of Fibrosis Following Hepatitis C Eradication.丙型肝炎根除后纤维化的消退
Gastroenterol Hepatol (N Y). 2022 Oct;18(10):599-601.
2
Direct antiviral agent treatment leads to rapid and significant fibrosis regression after HCV eradication.直接抗病毒药物治疗可在 HCV 清除后迅速显著地逆转肝纤维化。
J Viral Hepat. 2021 Sep;28(9):1284-1292. doi: 10.1111/jvh.13558. Epub 2021 Jun 20.
3
Viral eradication reduces all-cause mortality, including non-liver-related disease, in patients with progressive hepatitis C virus-related fibrosis.在患有进行性丙型肝炎病毒相关纤维化的患者中，病毒根除可降低全因死亡率，包括非肝脏相关疾病导致的死亡率。
J Gastroenterol Hepatol. 2017 Mar;32(3):687-694. doi: 10.1111/jgh.13589.
4
Evaluation of the association of a variant in PNPLA3 and TM6SF2 with fibrosis progression in patients with chronic hepatitis C infection after eradication: A retrospective study.评估 PNPLA3 和 TM6SF2 变异与慢性丙型肝炎感染患者根除后纤维化进展的相关性：一项回顾性研究。
Gene. 2022 Apr 30;820:146235. doi: 10.1016/j.gene.2022.146235. Epub 2022 Feb 7.
5
Serum angiopoietin-2 levels predict regression of Mac-2 binding protein glycosylation isomer-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents.血清血管生成素-2水平可预测丙型肝炎病毒经直接抗病毒药物清除后，基于Mac-2结合蛋白糖基化异构体的肝纤维化的消退情况。
Hepatol Res. 2022 Nov;52(11):919-927. doi: 10.1111/hepr.13823. Epub 2022 Aug 26.
6
Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C Virus.丙型肝炎病毒根除后慢性丙型肝炎患者肝纤维化实验室指标的预测能力
PLoS One. 2015 Jul 27;10(7):e0133515. doi: 10.1371/journal.pone.0133515. eCollection 2015.
7
Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis.直接作用抗病毒药物清除丙型肝炎病毒可改善严重肝纤维化患者的颈动脉粥样硬化。
J Hepatol. 2018 Jul;69(1):18-24. doi: 10.1016/j.jhep.2018.02.015. Epub 2018 Mar 2.
8
Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication.丙型肝炎病毒根除后纤维化生物标志物软骨寡聚基质蛋白持续升高。
World J Hepatol. 2019 Mar 27;11(3):330-334. doi: 10.4254/wjh.v11.i3.330.
9
Analysis of hepatic stiffness after viral eradication in a population with chronic hepatitis C treated with DAAs.在接受直接抗病毒药物（DAAs）治疗的慢性丙型肝炎患者群体中，病毒清除后肝脏硬度的分析。
Med Clin (Barc). 2021 Apr 9;156(7):317-323. doi: 10.1016/j.medcli.2020.04.050. Epub 2020 Aug 9.
10
Non-Invasive Indirect Markers of Liver Fibrosis after Interferon-Free Treatment for Hepatitis C.丙型肝炎无干扰素治疗后肝纤维化的非侵入性间接标志物
J Clin Med. 2021 Aug 31;10(17):3951. doi: 10.3390/jcm10173951.
引用本文的文献
1
Impact of Weight Loss on Metabolic Dysfunction Associated Steatohepatitis and Hepatic Fibrosis.体重减轻对代谢功能障碍相关脂肪性肝炎和肝纤维化的影响。
Curr Diab Rep. 2025 Feb 18;25(1):23. doi: 10.1007/s11892-025-01579-1.
2
Serum omentin-1 is correlated with the severity of liver disease in patients with chronic hepatitis C.血清网膜素-1与慢性丙型肝炎患者的肝病严重程度相关。
World J Hepatol. 2023 Dec 27;15(12):1315-1324. doi: 10.4254/wjh.v15.i12.1315.
本文引用的文献
1
Regression of liver fibrosis and hepatocellular carcinoma development after HCV eradication with oral antiviral agents.口服抗病毒药物清除 HCV 后肝纤维化和肝细胞癌发展的消退。
Sci Rep. 2022 Jan 7;12(1):193. doi: 10.1038/s41598-021-03272-1.
2
Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside.丙型肝炎病毒清除后的肝纤维化逆转：从基础到临床。
Gastroenterology. 2021 Apr;160(5):1502-1520.e1. doi: 10.1053/j.gastro.2020.09.065. Epub 2021 Jan 30.
3
Fibrosis reversal after hepatitis C virus elimination.丙型肝炎病毒清除后的肝纤维化逆转。
Curr Opin Gastroenterol. 2019 May;35(3):137-144. doi: 10.1097/MOG.0000000000000524.
4
Noninvasive Assessment of Fibrosis Regression in Hepatitis C Virus Sustained Virologic Responders.丙型肝炎病毒持续病毒学应答者纤维化消退的无创评估
Gastroenterol Hepatol (N Y). 2017 Oct;13(10):587-595.
5
American Gastroenterological Association Institute Clinical Practice Update-Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection.美国胃肠病学会协会临床实践更新-专家评论：慢性丙型肝炎感染抗病毒治疗后获得持续病毒学应答患者的治疗。
Gastroenterology. 2017 May;152(6):1578-1587. doi: 10.1053/j.gastro.2017.03.018. Epub 2017 Mar 23.
Zotero 插件